| Literature DB >> 34719851 |
Yan Zhao1, Jing-Jing Zhao2, Jia-Xin Guo3, Shuang-Qing Liu4, Yang Li5, Xiao-Yi Wang6, Rong Li2, Hui-Qin Tang5, Zhen-Yu Li7, Hui-Fen Yang1, Bing Chen7.
Abstract
The treatment of subcutaneous abscess caused by drug-resistant bacteria is facing great difficulties and receiving more attention. In this work, we employed BSA-CuS nanoparticles as a photothermal reagent to apply photothermal therapy (PTT) to combat drug-resistant bacteria in vitro and subcutaneous abscess in vivo. The BSA-CuS nanoparticles were found to be stable and biocompatible without cytotoxicity toward NIH3T3 and 4T1 cells. In vitro experiments showed that three species of drug-resistant pathogens, including Escherichia coli, Staphylococcus aureus, and Candida albicans, could be effectively sterilized under co-incubation with BSA-CuS nanoparticles and then irradiation with 1064 nm NIR laser via tissue penetration. BSA-CuS nanoparticles together with 1064 nm NIR laser irradiation could also effectively diminish subcutaneous abscesses caused by drug-resistant bacteria on mice under PTT and depth PTT without causing any serious side effects and organic damage in vivo.That is OK, thank you!Entities:
Keywords: BSA-CuS; drug-resistant pathogen; near infrared; photothermal therapy; sterilization
Mesh:
Substances:
Year: 2021 PMID: 34719851 DOI: 10.1002/cmdc.202100570
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466